Patient Guide: A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 23 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT03745924
Status: ENROLLING_BY_INVITATION
Condition: Haemophilia B
Phase: Not Specified

Where You Can Participate

This study is available at 23 locations across the country.

Top locations include:
  • • Vienna,
  • • Brussels,
  • • Edmonton, Alberta
  • • And 20 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN - Join Clinical Trial NCTNCT03745924

How to Join This Clinical Trial - NCTNCT03745924

Learn how to participate in this Not Specified trial studying an investigational therapy for Haemophilia B. Current status: ENROLLING_BY_INVITATION.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Haemophilia B. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Haemophilia B
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
ENROLLING_BY_INVITATION
Study Identifier
NCTNCT03745924 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 23 locations. Find a study site near you:

Clinical Research Site

Vienna, 1090 - Austria

Status: Contact for availability

Clinical Research Site

Brussels, 1200 - Belgium

Status: Contact for availability

Clinical Research Site

Edmonton, Alberta T6G 2V2 - Canada

Status: Contact for availability

Clinical Research Site

Winnipeg, Manitoba R3E 0V9 - Canada

Status: Contact for availability

Clinical Research Site

St. John's, Newfoundland and Labrador A1B 3V6 - Canada

Status: Contact for availability

Clinical Research Site

Hamilton, Ontario L8N 3Z5 - Canada

Status: Contact for availability

Clinical Research Site

Hamilton, Ontario L8N 3Z5 - Canada

Status: Contact for availability

Clinical Research Site

Toronto, Ontario M5G 1X8 - Canada

Status: Contact for availability

Clinical Research Site

Zagreb, 10 000 - Croatia

Status: Contact for availability

Clinical Research Site

Brno, 625 00 - Czechia

Status: Contact for availability

And 13 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Haemophilia B:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships